期刊文献+

地特胰岛素联合阿卡波糖对糖尿病患者脂联素和胰岛素抵抗的影响 被引量:10

下载PDF
导出
摘要 目的:探讨地特胰岛素联合阿卡波糖对2型糖尿病患者脂联素(APN)水平及胰岛素抵抗(IR)的影响。方法:初次诊断的2型糖尿病患者80例随机分为治疗组和对照组,每组40例。对照组口服阿卡波糖片+二甲双胍片治疗;治疗组口服阿卡波糖片+皮下注射地特胰岛素注射液。观察两组患者血浆A.PN、胰岛素抵抗指数(HOMA-IR)的变化。结果:治疗后治疗组HOMA-IR明显低于对照组(P<0.05),外周血APN水平明显高于对照组(P<0.05)。治疗组血糖达标率为100%,对照组仅为77.5%,两组比较,差异有统计学意义(P<0.05);治疗组平均血糖达标时间为(8.12±1.60)d,对照组为(16.80±3.06)d,两组差异亦有统计学意义(P<0.05)。结论:患者在口服降糖药基础上皮下注射地特胰岛素,可显著提高血浆APN水平,改善患者IR现象,有助于提高临床血糖达标率,缩短血糖达标时间。.
出处 《中国药师》 CAS 2012年第1期94-96,共3页 China Pharmacist
  • 相关文献

参考文献7

二级参考文献41

  • 1廖勤,梁泽容,屈春梅.两种基础胰岛素类似物——地特胰岛素与甘精胰岛素治疗2型糖尿病临床效果比较[J].实用医院临床杂志,2010,7(4):42-44. 被引量:25
  • 2Ono T, Shiga N, Tanebe Y, et al. The fasting-plasma glucose range in which insulin resistance measured by homeostasis model assessment correlates with euglycemic clamping. J Jpn Diabet Soc, 1999,42:1005- 1011.
  • 3Taniguchi A, Fuknshima M, Ohya M, et al. Interleukin 6, adiponectin, leptin, and insulin resistance in no obese Japanese type 2 diabetic patients. Metabolism, 2006,55:258-262.
  • 4Yang C, Hiromi O, Hayano N, et al. Ratio of leptin to adiponectin as an obesity index of cynomolgus monkeys (Maeaca fascicularis). Exp Anim, 2003,52:13%143.
  • 5Leszczyszyn-Pynka M, Pynka S, Boren-Kaczmarska A, et al. Serum leptin and adiponectin concentrations in patients infected with human immunodeficiency virus type 1 (HIV-1) on antiretroviral therapy. Endokrynol Pol, 2005,56 : 19-24.
  • 6Katsuki A, Sunida Y, Gabazza EC, et al. Homeostasis model assessment is a reliable indicator of insulin resistance during follow-up of patients with type 2 diabetes. Diabetes Care, 2001,24:362-365.
  • 7陆志诚.地特胰岛索:作用时间长达一天[N].医药经济报,2006-01-25,C7版.
  • 8潘长玉,陆祖谦.新一代长效胰岛素:地特胰岛素[N].中国医学论坛报,2008-08-21.C8版.
  • 9Ellmer M, Hamilton WM, Kim SP,at al. Mechanism of action in dogs of slow- acting insulin analog 0346 [J]. Clin Erulocrinol Metab, 2003, 88 ( 5 ) : 2256- 2262.
  • 10Havelund S,Plum A,Ribel U, et al. The mechanism of protraction of insulin detemir, a long-acting, acylated analog of human insulin [ J ]. Pharm Res, 21304,8 : 1498-1504.

共引文献97

同被引文献90

  • 1庞家莲,蒙光义,王冬晓.地特胰岛素治疗2型糖尿病临床应用和疗效研究进展[J].医学信息(医学与计算机应用),2014,0(7):527-529. 被引量:1
  • 2陈秀林.地特胰岛素联合格列美脲对肥胖2型糖尿病患者胰岛素抵抗的影响[J].实用老年医学,2013,27(1):85-87. 被引量:6
  • 3王淑平,赵秀云.地特胰岛素联合阿卡波糖治疗血糖控制不佳的2型糖尿病患者的疗效[J].中国老年学杂志,2014,34(1):243-244. 被引量:9
  • 4Vettickattuparambil George Giby,Thekkuttuparambil Ananthanarayanan Ajith.Role of adipokines and peroxisome proliferator-activated receptors in nonalcoholic fatty liver disease[J].World Journal of Hepatology,2014,6(8):570-579. 被引量:30
  • 5Ma H, Gomez V, Lu L, et al. Expression of adiponectin and its re- ceptors in livers of morbidly obese patients with non-alcoholic fatty liv- er disease [ J ]. J Gastroenterol Hepatol, 2009 , 24 ( 2 ) :233-237.
  • 6Liu Y, Michael MD, Kash S, et al. Deficiency of adiponectin recep- tor 2 reduces diet-induced insulin resistance but promotes type 2 dia- betes [J]. Endocrinology, 2007, 148(2):683-692.
  • 7Tomita K, Oike Y, Teratani T, et al. Hepatic AdipoR2 signaling plays a protective role against progression of nonalcoholic steatohepati- tis in mice[ J]. Hepatology, 2008,48:458-473.
  • 8Oishi M,Abe N,Yokoyama H,et al.Observational 6-month openlabel study of Japanese type 2 diabetes patients switching from NPH insulin to insulin detemir in basal-bolus regimen:23rd article of the Japan diabetes clinical data management study group(JDDM23)[J].J Int Med Res,2012,40(2):787-797
  • 9Khunti K,Caputo S,Damci T,et al.The safety and efficacy of adding once-daily insulin detemir to oral hypoglycaemic agents in patients with type 2 diabetes in a clinical practice setting in 10 countries[J].Diabetes Obes Metab,2012,14(12):1129-1136
  • 10Herrmann BL,Kasser C,Keuthage W,et al.Comparison of insulin aspart vs regular human insulin with or without insulin detemir concerning adipozytokines and metabolic effects in patients with type 2 diabetes mellitus[J].Exp Clin Endocrinol Diabetes,2013,121(4):210-213

引证文献10

二级引证文献58

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部